Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
granisetron hydrochloride, Quantity: 1.12 mg/mL (Equivalent: granisetron, Qty 1 mg/mL)
Atnahs Pharma Australia Pty Ltd
Injection, solution
Excipient Ingredients: hydrochloric acid; citric acid monohydrate; sodium chloride; water for injections; sodium hydroxide
Intravenous
1 x 3mL ampoules
(S4) Prescription Only Medicine
Adults: KYTRIL (tablets and injection) is indicated for use in adults for: The prevention of nausea and vomiting induced by cytotoxic chemotherapy; The prevention of nausea and vomiting induced by radiotherapy. KYTRIL (injection) is also indicated for use in the treatment of nausea and vomiting induced by cytotoxic chemotherapy; and prevention and treatment of post-operative nausea and vomiting.,Paediatric: KYTRIL injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy..
Visual Identification: Clear, colourless liquid.; Container Type: Ampoule; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2003-12-02
KYTRIL ® INJECTION _PRONOUNCED (KAI-TRIL)_ _contains the active ingredient granisetron hydrochloride_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about KYTRIL ampoules for injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given KYTRIL against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT KYTRIL IS USED FOR KYTRIL contains the active ingredient granisetron. KYTRIL belongs to a group of medicines called anti-emetics. KYTRIL is given to stop you feeling sick (nauseous) or being sick (vomiting). It is especially useful when you need to have medical treatment that may cause you to feel or be sick, for example, chemotherapy, radiotherapy or surgery. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY KYTRIL HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is not addictive. It is available only with a doctor's prescription. BEFORE YOU ARE GIVEN KYTRIL _WHEN YOU MUST NOT BE GIVEN_ _IT_ YOU MUST NOT BE GIVEN KYTRIL IF YOU HAVE AN ALLERGY TO: • any medicine containing granisetron • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or breathing difficulty; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. IF YOU ARE NOT SURE WHETHER YOU SHOULD BE GIVEN KYTRIL, TALK TO YOUR DOCTOR. _BEFORE YOU ARE GIVEN IT_ TELL YOUR DOCTOR IF: • YOU HAVE ALLERGIES TO ANY OTHER MEDICINES, FOODS, PRESERVATIVES OR DYES. • YOU HAVE HAD AN ALLERGIC REACTION WITH OTHER MEDICINES USED TO PREVENT OR TREAT NAUSEA AND VOMITING, SUCH AS ONDANSETRON AND TROPISETRON. You may have Read the complete document
Kytril® PI 1 AUSTRALIAN PRODUCT INFORMATION - KYTRIL ® (GRANISETRON HYDROCHLORIDE) 1. NAME OF THE MEDICINE Granisetron hydrochloride 2. QUALITATIVE AND QUANTITATIVE COMPOSITION KYTRIL INJECTIONS: KYTRIL injection is available as an ampoule containing granisetron hydrochloride, equivalent to 3 mg of granisetron free base in 3 mL; and equivalent to 1 mg of granisetron free base in 1 mL. KYTRIL TABLETS: KYTRIL tablets contain granisetron hydrochloride (equivalent to 2 mg of granisetron free base). KYTRIL tablets do not contain sucrose, gluten, tartrazine, or azo dyes. EXCIPIENTS WITH KNOWN EFFECT: contains sugars as lactose. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3. PHARMACEUTICAL FORM KYTRIL tablet: white to almost white, triangular biconvex, film-coated tablet, debossed with "K2" on one face. KYTRIL injection: sterile clear, colourless solution for injection. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ADULTS: KYTRIL (tablets and injection) is indicated for use in adults for: The prevention of nausea and vomiting induced by cytotoxic chemotherapy; The prevention of nausea and vomiting induced by radiotherapy. KYTRIL (injection) is also indicated for use in the treatment of nausea and vomiting induced by cytotoxic chemotherapy; and prevention and treatment of post-operative nausea and vomiting. PAEDIATRIC: KYTRIL injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy. 4.2 DOSE AND METHOD OF ADMINISTRATION DOSE Standard Dosage by presentation and indication for adult and paediatric patients are shown below. INDICATION: CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) _ADULTS _ _Oral Administration _ _Prevention of nausea and vomiting in adults _ The dose of KYTRIL is 2 mg once a day for up to one week following chemotherapy. The first dose of KYTRIL should be administered within 1 hour before the start of chemotherapy. _Treatment of established nausea and vomiting in adults _ There is insufficient information to recommend the oral adm Read the complete document